Table 1 Descriptive data of the studied group

Age (months)

46 ± 55.6

12

(1.6–168)

32.8 ± 40.6

12.0

(2–132)

59.9 ± 65.3

14.5

(1.6–168)

M.W

6.5

0.04*

Sex (N and %)

 Female

 Male

32 (53.3%)

28 (46.7%)

17 (53.1%)

13 (46.4%)

15 (49.9%)

15 (53.6%)

χ ²

0.2

0.6

HR (per minute)

128.9 ± 21.9

130 (81–172)

124.77 ± 22.14

125 (87–166)

132.97 ± 21.35

130 (81–172)

t = 1.4

0.1

RR per minute

28.9 ± 15.8

24 (16–91)

23.5 ± 3.1

24 (20–33)

35.1 ± 21.6

25 (16–91)

M.W

2.2

0.03*

DBP (mmHg)

66.7 ± 14.9

66 (35–97)

69.3 ± 14.6

73.5 (40–94)

64.1 ± 14.6

64 (35–97)

t = 1.4

0.1

SBP (mmHg)

107.2 ± 20.1

104.5 (68–151)

110.3 ± 19.9

110 (68–149)

104.2 ± 20.2

103.5 (68–151)

t = 1.2

0.2

Sepsis severity

 Severe sepsis

 Septic shock

22

38

9 (40.9%)

21 (55.3%)

13 (59.1%)

17 (44.7%)

1.1

0.3

Mechanical ventilation

 Yes

 No

42

18

12 (28.6%)

18 (100%)

30 (71.4%)

0 (0%)

25.714

0.000**

PICU stay (days)

13.3 ± 7.2

13.0

(2–30)

13.4 ± 6.5

14

(3–30)

13.2 ± 8.1

12

(2–30)

M.W

0.07

0.9

PRISM III score (0–74/23)

17.2 ± 6.4

17

(6–36)

14.6 ± 5.04

15.5

(6–25)

19.8 ± 6.6

20

(7–36)

M.W

3.4

0.001**

PSOFA score (0–24)

8.1 ± 3.07

8

(2–16)

6.8 ± 2.6

6

(2–12)

9.37 ± 3.06

9

(4–16)

M.W

3.5

0.001**

Total WBCs (10⁹/L)

14.5 ± 7.8

12.7

(3.4–38.5)

13.6 ± 7.17

13.4

(3.4–29.0)

15.3 ± 8.4

12.7

(6.4–38.5)

M.W

0.8

0.4

Procalcitonin (ng/ml)

17.8 ± 30.7

3.2

(0.2–100)

12.5 ± 23.3

2.5

(0.02–100)

23.2 ± 36.2

4.7

(0.03–100)

M.W

1.3

0.17

CRP (mg/L)

63.7 ± 80.2

24.7

(0.06–336.1)

38.8 ± 47.5

11.9

(0.06–142.2)

88.5 ± 97.7

57.2

(0.66–336.1)

M.W

2.5

0.01*

INR

1.2 ± 0.42

1.13

(0.1–2.38)

1.07 ± 0.23

1.1

(0.1–1.42)

1.35 ± 0.52

1.15

(0.45–2.38)

M.W

2.6

0.01*